Palantir Adds Former UK Labour Deputy Leader Tom Watson as £330M NHS Contract Faces Scrutiny

Palantir Technologies (NYSE: PLTR) has appointed Tom Watson, the former deputy leader of the UK Labour Party, to its ranks, according to a report by The Register. The hiring lands at a sensitive moment for the company, with its £330 million contract with the National Health Service (NHS) — the UK’s publicly funded health system — reportedly approaching a critical juncture.

Watson served as Labour’s deputy leader from 2015 to 2019 and has since built a portfolio of private-sector roles. His arrival gives Palantir a politically connected figure with deep familiarity with Westminster as the company works to sustain and expand its footprint in UK public-sector data infrastructure.

The NHS contract, awarded in late 2023, has drawn ongoing attention from lawmakers, clinicians, and privacy advocates concerned about how patient data is handled by outside technology providers. Reports suggest the agreement is nearing a decision point on its future, adding pressure on Palantir’s UK government relations efforts at precisely the time Watson joins.

Palantir, headquartered in Denver and known for its Gotham and Foundry software platforms, generates a substantial portion of its revenue from government customers, including defence and intelligence agencies in the United States and allied nations such as the United Kingdom. The company’s UK public-sector work has become an increasingly visible piece of its international business.

Market reaction to the news was muted. Shares of Palantir traded at $170.50, down 0.07% from the previous close of $170.62, valuing the software infrastructure company at roughly $439.7 billion.

For Palantir, the appointment signals a continued emphasis on navigating complex public-sector relationships in Europe, where government technology contracts frequently face political and regulatory headwinds. For Watson, the move represents a return to a company whose UK ambitions he is well positioned to support through his political network.

Neither Palantir nor Watson’s office has publicly detailed the scope of his role, and the NHS has not announced a final decision on the contract’s status.

What to watch

• Any formal announcement from NHS England or the UK Department of Health and Social Care regarding the £330 million contract’s continuation or restructuring.
• Details from Palantir on Watson’s title, responsibilities, and start date.
• Palantir’s upcoming quarterly earnings, where UK government revenue commentary may offer clarity on international pipeline stability.
• Parliamentary or regulatory inquiries into NHS data-handling arrangements with external technology vendors.

Source: original release